Atypical MOLes and Melanoma Early Detection Study (MoleMed) (MoleMed)
A Multicenter, Ambispective, Low-interventional Clinical Study Evaluating Molecular Genetic Markers for Non-invasive Differential Diagnosis of Benign and Malignant Pigmented Skin and Mucosal Neoplasms
Sponsor: Blokhin's Russian Cancer Research Center
Listed as NCT04353050, this NA trial focuses on Dysplastic Nevus Syndrome and Melanoma and remains ongoing. Sponsored by Blokhin's Russian Cancer Research Center, it has been updated 7 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Blokhin's Russian Cancer Research Center
- Russian Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .